CMRG provides patients with access to innovative clinical trials, supports better use of real-world data to understand treatment outcomes, and helps accelerate the development of new diagnostics and therapies that can improve care in Canada.

CMRG brings together clinical trials, a national real-world evidence database, and a growing biobank into one integrated research platform. This allows discoveries in the lab to be quickly connected to real patient outcomes and clinical practice.

CMRG is made up of more than 20 leading cancer centres across Canada, along with clinicians, researchers, data specialists, and patient partners who work together to advance myeloma research.

The CMRG Database is Canada’s largest prospective real-world dataset for multiple myeloma. It collects information on treatments, outcomes, and safety to help researchers, clinicians, and policymakers better understand how therapies work in everyday care.

The CMRG Biobank is a national program that collects and stores patient samples linked to clinical and real-world data. It supports biomarker discovery, precision medicine, and the development of new diagnostic and treatment approaches.

Patients can participate through CMRG-supported trials or the database at participating centres. Clinicians and partners can collaborate by proposing studies, contributing data, or supporting research through partnerships and funding.